Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.The biopsy diagnosed as oral squamous cell carcinoma. 2.The specimen diagnosed, the patients who are diagnosed as oral squamous cell carcinoma. 3.The patients with the histological diagnosis of oral squamous cell carcinoma. 4.The patients with the histological diagnosis of oral squamous cell carcinoma irrespective of grade of tumour. 5.The patients having adequate clinical details in regard of the oral squamous cell carcinoma.
Exclusion criteria
Exclusion criteria: 1. The patients diagnosed of oral squamous cancer of oral cavity other than squamous cell carcinomas. 2.The patients having inadequate details pertaining to histopathological diagnosis. 3. The patients having inadequate tumour tissue block which are inadeqaute to be porocessed for immunostaining for CD44 and TROP2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study involves research on tumour budding and investigates the immunoexpression of CD44 and TROP2 in oral squamous cell carcinoma (OSCC) tumour cells and examines their correlation with tumor grade T, lymph node status N and metastatsis M.Timepoint: Assessment will be done at 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Datta Meghe Institute of Higher Education and Research (DMIHER)